Clinical neurochemistry, a specialized field within neuroscience, delves deeply into the intricate chemical processes and neurotransmitter systems operating within the nervous system. This branch focuses keenly on elucidating the mechanisms underlying neurological and psychiatric disorders. At its core, neurotransmitters serve as the pivotal messengers transmitting signals among neurons in the brain, exerting profound influence over a myriad of physiological and psychological functions. Serotonin, dopamine, norepinephrine, glutamate, and gamma-aminobutyric acid (GABA) stand as quintessential neurotransmitters, governing aspects ranging from mood regulation and cognition to behavior and emotion. Within the realm of clinical neurochemistry, experts meticulously investigate the synthesis, release, reuptake, and metabolism of these neurotransmitters. By discerning alterations within these systems, researchers gain crucial insights into the pathophysiology of various disorders. Conditions such as depression, anxiety, schizophrenia, bipolar disorder, Parkinson's disease, Alzheimer's disease, and substance use disorders all fall under the purview of clinical neurochemists' scrutiny. Employing a diverse array of research methodologies, including biochemical assays, neuroimaging techniques like PET and SPECT scans, pharmacological studies, and genetic analyses, these scientists meticulously unravel the neurochemical intricacies underpinning these ailments. Through such multifaceted approaches, they endeavor to uncover the subtle yet profound ways in which neurotransmitter dysregulation contributes to disease manifestation. However, the ultimate goal extends far beyond mere comprehension; clinical neurochemists aspire to leverage this knowledge to pioneer novel pharmacological treatments and interventions. By targeting specific neurochemical pathways, they aim to alleviate symptoms, enhance quality of life, and nurture brain health. This pursuit of innovative therapeutics underscores the transformative potential inherent in deciphering the neurochemical underpinnings of neurological and psychiatric disorders. In essence, clinical neurochemistry represents a dynamic field at the nexus of cutting-edge scientific inquiry and tangible clinical impact. Its practitioners, armed with an arsenal of sophisticated tools and methodologies, strive tirelessly to unravel the intricate tapestry of neurotransmitter dynamics. Through their relentless dedication, they illuminate the path towards novel therapeutic avenues, holding promise for countless individuals grappling with the burdens of neurological and psychiatric afflictions.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States